Study of E7389 in Patients With Advanced Solid Tumors
To determine the maximum tolerated dose of E7389 in patients with advanced solid tumors that have progressed following standard therapy or for which no standard therapy exists.
Advanced Solid Tumors
DRUG: E7389
Determination of the Maximum Tolerated Dose, 28 Days
To determine the maximum tolerated dose of E7389 in patients with advanced solid tumors that have progressed following standard therapy or for which no standard therapy exists.